NCT07186894View on ClinicalTrials.gov

Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia

Active, not recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

January 1, 2000

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
BacteriemiaMethicillin Susceptible Staphylococcus Aureus (MSSA) Infection
Interventions
DRUG

Antistaphylococcal penicillins

It in not an interventional study. This project is a phase IV, retrospective, descriptive, and multicentric study.

DRUG

Cefazolin

It in not an interventional study. This project is a phase IV, retrospective, descriptive, and multicentric study.

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT07186894 - Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia | Biotech Hunter | Biotech Hunter